About the Study
This clinical trial is designed for adult males (18-60) and females (18-70) with alopecia areata causing hair loss on more than 50% of the scalp. To qualify, participants must be experiencing an episode lasting less than 8 years with stable hair loss over the past 6 months. The study lasts approximately 65 weeks and involves 24 clinic visits to closely monitor treatment progress and safety.